Cardinal Health (NYSE:CAH) Now Covered by Mizuho

Mizuho began coverage on shares of Cardinal Health (NYSE:CAH) in a research note issued to investors on Wednesday. The brokerage set an “outperform” rating and a $139.00 price target on the stock. Mizuho’s price target would indicate a potential upside of 12.79% from the company’s current price.

Other research analysts have also issued reports about the company. UBS Group lifted their price objective on Cardinal Health from $134.00 to $139.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. Argus boosted their price target on Cardinal Health from $115.00 to $125.00 and gave the company a “buy” rating in a research note on Wednesday, September 11th. JPMorgan Chase & Co. raised their price objective on shares of Cardinal Health from $111.00 to $123.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 21st. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Finally, Barclays increased their target price on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a research note on Monday, November 4th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus price target of $124.58.

Cardinal Health Price Performance

CAH opened at $123.24 on Wednesday. The company’s 50 day moving average price is $115.43 and its two-hundred day moving average price is $107.16. The firm has a market capitalization of $29.83 billion, a price-to-earnings ratio of 23.98, a PEG ratio of 1.53 and a beta of 0.61. Cardinal Health has a fifty-two week low of $93.17 and a fifty-two week high of $126.14.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. The company had revenue of $52.28 billion during the quarter, compared to analysts’ expectations of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The business’s quarterly revenue was down 4.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.73 earnings per share. As a group, equities research analysts predict that Cardinal Health will post 7.82 EPS for the current year.

Institutional Investors Weigh In On Cardinal Health

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Eastern Bank purchased a new stake in Cardinal Health in the 3rd quarter valued at $25,000. Cultivar Capital Inc. bought a new position in shares of Cardinal Health during the second quarter valued at about $27,000. Frazier Financial Advisors LLC boosted its holdings in Cardinal Health by 69.8% during the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after purchasing an additional 104 shares during the last quarter. Ashton Thomas Private Wealth LLC purchased a new stake in Cardinal Health in the 2nd quarter valued at about $29,000. Finally, Hara Capital LLC bought a new position in shares of Cardinal Health during the 3rd quarter worth approximately $31,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.